How often should I retest my blood biomarkers?

Short answer: It depends on the biomarker, your health status, medications, and whether a result was abnormal. Below is a practical schedule you can use and the common reasons to test more or less often.

Typical retest intervals (healthy adult, stable results)

• Basic metabolic panel (electrolytes, kidney/liver function): annually. Sooner if you start new medications that affect kidneys/liver or have chronic disease.
• Complete blood count (CBC): annually. Repeat sooner for unexplained anemia, bleeding, or infection.
• Lipid panel (total cholesterol, LDL, HDL, triglycerides): every 4–6 years for low-risk adults; annually if you have cardiovascular risk factors or are on/change statins.
• Hemoglobin A1c (diabetes screening/monitoring): every 3 years if normal and low-risk; every 3 months if you have diabetes and are changing therapy or not at goal; every 6 months if diabetes is stable.
• Fasting glucose (or random glucose): annually for most adults; earlier if overweight/other risk factors.
• Thyroid-stimulating hormone (TSH): every 6–12 months if you are on thyroid therapy or have abnormal TSH; every 1–2 years if previously normal and asymptomatic.
• Vitamin D (25‑OH D): only test if deficiency suspected or you’re treating deficiency; recheck ~8–12 weeks after starting supplements, then every 6–12 months if ongoing therapy.
• Ferritin/iron studies: repeat 2–3 months after treatment for deficiency or sooner if symptoms persist.
• High-sensitivity CRP and other inflammatory markers: only as clinically indicated, not routine.
• PSA (prostate-specific antigen): frequency varies by age/risk and shared decision-making—commonly every 1–2 years in men who choose screening.
• Special tests (hormones, autoimmune markers, tumor markers): follow your specialist’s schedule.

When to test more frequently

• Starting or changing medications (statins, thyroid meds, diabetes drugs, anticoagulants).
• New or worsening symptoms.
• Known chronic conditions (diabetes, chronic kidney disease, heart disease).
• Recent abnormal result — follow-up testing until stable.

When less frequent testing is reasonable

• Young, healthy people with repeatedly normal results and low risk factors.

Where to get tests (options and why)

• Local primary care or health system labs (Labcorp, Quest Diagnostics): comprehensive panels, widely accepted by clinicians and insurance.
• Direct-to-consumer at-home kits (Everlywell, LetsGetChecked): convenient for screening and monitoring simple markers; good if you need convenience but confirm abnormal results with a clinical lab/doctor.
• Personalized biomarker services (InsideTracker, WellnessFX): offer trend tracking and lifestyle recommendations — useful if you want data-driven coaching, but expect added cost.
• Continuous monitoring (if relevant): Dexcom or FreeStyle Libre for people who need ongoing glucose tracking (diabetes or metabolic optimization).
• Telehealth/primary-care platforms (One Medical, Forward, your insurance’s telehealth): helpful for interpretation and follow-up.

Final notes

• These are general recommendations. Individual frequency should be tailored to your age, family history, medications, and medical conditions. Talk with your clinician to set a testing schedule.
• If you want, tell me your age, major medical conditions, medications, and any recent abnormal labs and I can suggest a more specific retesting plan.